US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NeuroBo Pharmaceuticals, Inc.

2.36

+0.0000

Volume:- -

Turnover:31.15K

Market Cap:20.33M

PE:-0.55

High:2.36

Open:2.36

Low:2.36

Close:2.36

Loading ...

Overview Company News Filings

NeuroBo Pharmaceuticals Completes Enrollment of the SAD Part 1 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity

NeuroBo Pharmaceuticals Inc - Financial Terms of Agreement Were Not Disclosed

THOMSON REUTERS

NeuroBo Pharmaceuticals Announces Joint Research Agreement, Together With Dong-a St and Immunoforge to Develop a Long-Acting Once-Monthly Formulation of Da-1726 for the Treatment of Obesity

THOMSON REUTERS

NeuroBo Pharmaceuticals Announces Joint Research Agreement, Together with Dong-A ST and ImmunoForge to Develop a Long-Acting Once-Monthly Formulation of DA-1726 for the Treatment of Obesity

NeuroBo Pharmaceuticals Inc expected to post a loss of $1.12 a share - Earnings Preview

NeuroBo Pharmaceuticals Strikes Licensing Deal for NB-01

NeuroBo Pharmaceuticals Announces Exclusive License Agreement With Mthera Pharma for NB-01

THOMSON REUTERS

NeuroBo Pharmaceuticals Inc - Financial Terms of Agreement Were Not Disclosed.

THOMSON REUTERS

NeuroBo Pharmaceuticals Announces Exclusive License Agreement with MThera Pharma for NB-01

NeuroBo Pharmaceuticals Releases Corporate Presentation Update

NeuroBo Pharmaceuticals to Present at the Emerging Growth Conference in July

NRBO: DA-1726 Shows Superiority to Survodutide in Pre-Clinical Models…

Zacks Small Cap Research

BRIEF-Neurobo Pharmaceuticals Doses First Patient In The Mad Part 2 Of Its Phase 1 Clinical Trial Evaluating DA-1726 For The Treatment Of Obesity

NeuroBo Pharmaceuticals Doses First Patient in the Mad Part 2 of Its Phase 1 Clinical Trial Evaluating Da-1726 for the Treatment of Obesity

THOMSON REUTERS

NeuroBo Pharmaceuticals: Top-Line Data Readout From Single Ascending Dose Part 1 Expected in Q3 2024 & From Multiple Ascending Dose Part 2 in Q1 2025

THOMSON REUTERS

NeuroBo Pharmaceuticals Inc: Planned Part 3 Interim Data Readout Expected Mid-2026 With Top-Line Data in Second Half of 2026

THOMSON REUTERS

NeuroBo Pharmaceuticals Doses First Patient in the MAD Part 2 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity

NeuroBo Pharmaceuticals Raises $20 Million from Share Placement

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NRBO/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NRBO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRBO\",,,,,undefined,":{"symbol":"NRBO","market":"US","secType":"STK","nameCN":"NeuroBo Pharmaceuticals, Inc.","latestPrice":2.36,"timestamp":1732741200000,"preClose":2.36,"halted":8,"volume":0,"delay":0,"floatShares":2196834,"shares":8616010,"eps":-4.294645,"marketStatus":"Market Closed","change":0,"latestTime":"11-27 16:00:00 EST","open":2.36,"high":2.36,"low":2.36,"amount":31147.715098499997,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.294645,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"symbolChange":{"newSymbol":"MTVA","executeDate":"2024-11-29"},"adr":0,"listingDate":1470369600000,"exchange":"NASDAQ","adjPreClose":2.36,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRBO\",,,,,undefined,":{"symbol":"NRBO","floatShares":2196834,"roa":"-74.35%","roe":"-160.76%","lyrEps":-2.459032,"shares":8616010,"dividePrice":0,"high":2.36,"amplitude":0,"preClose":2.36,"low":2.36,"week52Low":2.08,"pbRate":"1.57","week52High":6.7499,"institutionHeld":0,"latestPrice":2.36,"eps":-4.294645,"divideRate":0,"volume":0,"delay":0,"ttmEps":-4.294645,"open":2.36},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NRBO\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2459970064","title":"NeuroBo Pharmaceuticals Completes Enrollment of the SAD Part 1 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2459970064","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459970064?lang=en_us&edition=fundamental","pubTime":"2024-08-13 20:01","pubTimestamp":1723550460,"startTime":"0","endTime":"0","summary":"No Significant Issues Encountered During the Single Ascending Dose  Study, Allowing for Previously Reported Accelerated Start to Multiple Ascending Dose  Part 2. Top Line Data Readout from SAD Part 1 Expected in the Third Quarter of 2024, and from the MAD Part 2 in the First Quarter of 2025. Mr. Kim continued, \"Our estimated timelines for this program remain unchanged. We expect to report top-line data from the SAD Part 1 portion of the Phase 1 clinical trial in the third quarter of this year and top-line data from the MAD Part 2 in the first quarter of 2025. Further, upon clearance of an updated Investigational New Drug  application with the U.S. Food and Drug Administration , we expect to dose the first patient in the planned Part 3 of the trial during the third quarter of 2025, providing an interim data readout in or around mid-2026 and issuing top-line results in the second half of 2026.\"","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/0CkWDpKcRZ.MsMrgzsVc5g--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/117f84f95bc9f3e25299d859b0beb54b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/0CkWDpKcRZ.MsMrgzsVc5g--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/117f84f95bc9f3e25299d859b0beb54b"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/neurobo-pharmaceuticals-completes-enrollment-sad-120100066.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurobo-pharmaceuticals-completes-enrollment-sad-120100066.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU1169590202.USD","BK4157","BK4181","PK","OXM","BK4218","BK4202","BMI","PD","LU1169589451.USD","NRBO","BK4023"],"gpt_icon":0},{"id":"2457046979","title":"NeuroBo Pharmaceuticals Inc - Financial Terms of Agreement Were Not Disclosed","url":"https://stock-news.laohu8.com/highlight/detail?id=2457046979","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2457046979?lang=en_us&edition=fundamental","pubTime":"2024-08-06 20:01","pubTimestamp":1722945662,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240806:nTUA3T0JLR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NRBO"],"gpt_icon":0},{"id":"2457046941","title":"NeuroBo Pharmaceuticals Announces Joint Research Agreement, Together With Dong-a St and Immunoforge to Develop a Long-Acting Once-Monthly Formulation of Da-1726 for the Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2457046941","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2457046941?lang=en_us&edition=fundamental","pubTime":"2024-08-06 20:01","pubTimestamp":1722945662,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240806:nTUA3T0JLR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4185","BK4139","JYNT","NRBO"],"gpt_icon":0},{"id":"2457049432","title":"NeuroBo Pharmaceuticals Announces Joint Research Agreement, Together with Dong-A ST and ImmunoForge to Develop a Long-Acting Once-Monthly Formulation of DA-1726 for the Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2457049432","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2457049432?lang=en_us&edition=fundamental","pubTime":"2024-08-06 20:01","pubTimestamp":1722945660,"startTime":"0","endTime":"0","summary":"Collaboration to Leverage ImmunoForge's ELP Platform Technology Which Can Increase the Half-Life of a Drug by up to 200 Times. CAMBRIDGE, Mass., Aug. 6, 2024 /PRNewswire/ --NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it has signed a joint research agreement, together with Dong-A ST Co. Ltd. and ImmunoForge, to develop a long-acting, once-monthly, formulation of DA-1726, a novel, dual oxyntomodulin  analog agonist that functions as a glucagon-like peptide-1 receptor  and glucagon receptor , utilizing ImmunoForge's long-lasting half-life extension Elastin-Like Polypeptide  platform technology. Financial terms of the agreement were not disclosed.\"This agreement with Dong-A ST, one of the top pharmaceutical companies in Korea, and NeuroBo, reaffirms the potential of our ELP platform technology,\" added Sung-Min Ahn and Kiho Chang, Co-Chief Executive Officers of ImmunoForge. \"Our patented, once-","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/diH9YaGISL2gkeFgFnJx8g--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/d6bc2614c5164dee3a59fb0eb8d6762b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/diH9YaGISL2gkeFgFnJx8g--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/d6bc2614c5164dee3a59fb0eb8d6762b"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/neurobo-pharmaceuticals-announces-joint-research-120100610.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurobo-pharmaceuticals-announces-joint-research-120100610.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4081","BK4185","OXM","BK4202","NRBO","ELP","JYNT"],"gpt_icon":0},{"id":"2457720376","title":"NeuroBo Pharmaceuticals Inc    expected to post a loss of $1.12 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2457720376","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2457720376?lang=en_us&edition=fundamental","pubTime":"2024-08-05 21:29","pubTimestamp":1722864548,"startTime":"0","endTime":"0","summary":"* NeuroBo Pharmaceuticals Inc     is expected to show no change in quarterly revenue when it reports  results on August 7 (estimated) for the period ending June 30 2024   *    * LSEG's mean analyst es","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"NeuroBo Pharmaceuticals Inc    expected to post a loss of $1.12 a share - Earnings Preview","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRBO"],"gpt_icon":0},{"id":"2455932562","title":"NeuroBo Pharmaceuticals Strikes Licensing Deal for NB-01","url":"https://stock-news.laohu8.com/highlight/detail?id=2455932562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2455932562?lang=en_us&edition=fundamental","pubTime":"2024-07-30 20:58","pubTimestamp":1722344339,"startTime":"0","endTime":"0","summary":"An announcement from NeuroBo Pharmaceuticals (NRBO) is now available. NeuroBo Pharmaceuticals, Inc. has entered into an exclusive licensing agreeme...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurobo-pharmaceuticals-strikes-licensing-deal-for-nb-01?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurobo-pharmaceuticals-strikes-licensing-deal-for-nb-01?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NRBO","NB","BK4139","BK4168"],"gpt_icon":0},{"id":"2455939859","title":"NeuroBo Pharmaceuticals Announces Exclusive License Agreement With Mthera Pharma for NB-01","url":"https://stock-news.laohu8.com/highlight/detail?id=2455939859","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2455939859?lang=en_us&edition=fundamental","pubTime":"2024-07-30 20:01","pubTimestamp":1722340863,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240730:nTUA7Y7NZN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRBO","NB","BK4168","BK4139"],"gpt_icon":0},{"id":"2455398749","title":"NeuroBo Pharmaceuticals Inc - Financial Terms of Agreement Were Not Disclosed.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455398749","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2455398749?lang=en_us&edition=fundamental","pubTime":"2024-07-30 20:01","pubTimestamp":1722340863,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240730:nTUA7Y7NZN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRBO","BK4139"],"gpt_icon":0},{"id":"2455364529","title":"NeuroBo Pharmaceuticals Announces Exclusive License Agreement with MThera Pharma for NB-01","url":"https://stock-news.laohu8.com/highlight/detail?id=2455364529","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2455364529?lang=en_us&edition=fundamental","pubTime":"2024-07-30 20:01","pubTimestamp":1722340860,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., July 30, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases, today announcedthe signing of an exclusive license agreement, providing MThera Pharma Co., Ltd.  with the rights to NB-01 for the treatment of painful diabetic neuropathy. The agreement allowsMTHERA to conduct research and clinical trials, including, but not limited to, a potential Phase 3 clinical trial in the United Statesand South Korea, for the future commercialization of NB-01. Financial terms of the agreement were not disclosed.About NeuroBo Pharmaceuticals NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. The company is currently developing DA-1726 for the treatment of obesity, and is developing DA-1241 for the treatment of Metabolic Dysfunction-Associated Steatohepatitis . DA-1726 is a novel oxyntomod","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MmEJqqVsHCKYh5geKzXIrA--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/4b160b03f08bee8c854dc3ca3642274d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MmEJqqVsHCKYh5geKzXIrA--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/4b160b03f08bee8c854dc3ca3642274d"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/neurobo-pharmaceuticals-announces-exclusive-license-120100932.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurobo-pharmaceuticals-announces-exclusive-license-120100932.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OXM","BK4139","NRBO","NB","BK4168","BK4202"],"gpt_icon":0},{"id":"2451992808","title":"NeuroBo Pharmaceuticals Releases Corporate Presentation Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2451992808","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2451992808?lang=en_us&edition=fundamental","pubTime":"2024-07-16 20:58","pubTimestamp":1721134729,"startTime":"0","endTime":"0","summary":"NeuroBo Pharmaceuticals (NRBO) just unveiled an announcement. NeuroBo Pharmaceuticals, Inc. has made its latest corporate presentation available on...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurobo-pharmaceuticals-releases-corporate-presentation-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurobo-pharmaceuticals-releases-corporate-presentation-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NRBO"],"gpt_icon":0},{"id":"2450359162","title":"NeuroBo Pharmaceuticals to Present at the Emerging Growth Conference in July","url":"https://stock-news.laohu8.com/highlight/detail?id=2450359162","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450359162?lang=en_us&edition=fundamental","pubTime":"2024-07-11 20:01","pubTimestamp":1720699260,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., July 11, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. ,a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announcedthat Hyung Heon Kim, President and Chief Executive Officer and Marshall H. Woodworth, Chief Financial Officer, will present a company overview at the Emerging Growth Conference on Thursday, July 18, 2024 at 10:50 am ET.During the virtual presentation, management will provide an update on the clinical development of DA-1726, a novel, dual oxyntomodulin  analog agonist that functions as a glucagon-like peptide-1 receptor  and glucagon receptor , for the treatment of obesity.After the presentation, NeuroBo management will open the floor for questions. Please submit your questions in advance to questions@emerginggrowth.com,or ask your questions during the event.Please register using this linkto attend the virtual conference and receive any updates that are released. To schedule a meeting with management outsid","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/GzsCoNkMHLUJZTv2q_X2PQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/cffae62bf38d90dcb6341f31e012bf81","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/GzsCoNkMHLUJZTv2q_X2PQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/cffae62bf38d90dcb6341f31e012bf81"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/neurobo-pharmaceuticals-present-emerging-growth-120100039.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurobo-pharmaceuticals-present-emerging-growth-120100039.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OXM","BK4202","BK4139","NRBO"],"gpt_icon":0},{"id":"2448415139","title":"NRBO:  DA-1726 Shows Superiority to Survodutide in Pre-Clinical Models…","url":"https://stock-news.laohu8.com/highlight/detail?id=2448415139","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2448415139?lang=en_us&edition=fundamental","pubTime":"2024-07-01 22:47","pubTimestamp":1719845220,"startTime":"0","endTime":"0","summary":"On June 22, 2024, NeuroBo Pharmaceuticals, Inc.  announced that pre-clinical data for DA-1726, the company’s dual oxyntomodulin  analog agonist of glucagon-like peptide-1 receptor  and glucagon receptor , demonstrated superiority in weight loss, retention of lean body mass, and lipid-lowering effects compared to survodutide. The data was presented in a poster at the American Diabetes Association  84th Scientific Sessions. A copy of the poster can be found here.In this study, DIO mice were treated with 200 nmol/kg DA-1726 or 70 nmol/kg survodutide twice a week for three weeks. The following images show the change in body weight and food intake over the course of the three-week study. Both the survodutide- and DA-1726-treated animals showed a statistically significant decrease in body weight and food intake compared to the control mice. In addition, DA-1726 showed superior weight loss efficacy compared to survodutde in spite of the fact that DA-1726-treated mice consumed more food.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UJZimpL.WFQUaGn1J7Jofw--~B/aD0xMTc4O3c9MTE0NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/scr.zacks.com/ae48e344efe324bef1f88df6aae3c238","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UJZimpL.WFQUaGn1J7Jofw--~B/aD0xMTc4O3c9MTE0NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/scr.zacks.com/ae48e344efe324bef1f88df6aae3c238"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nrbo-da-1726-shows-superiority-144700215.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OXM","BK4202","BK4139","NRBO"],"gpt_icon":0},{"id":"2446739603","title":"BRIEF-Neurobo Pharmaceuticals Doses First Patient In The Mad Part 2 Of Its Phase 1 Clinical Trial Evaluating DA-1726 For The Treatment Of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2446739603","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446739603?lang=en_us&edition=fundamental","pubTime":"2024-06-26 21:51","pubTimestamp":1719409889,"startTime":"0","endTime":"0","summary":"June 26  - Neurobo Pharmaceuticals Inc :   * NEUROBO PHARMACEUTICALS DOSES FIRST PATIENT IN THE MAD PART 2 OF ITS PHASE 1 CLINICAL TRIAL EVALUATING DA-1726 FOR THE TREATMENT OF OBESITY   * NEUROBO PHARMACEUTICALS: TOP-LINE DATA READOUT FROM SINGLE ASCENDING DOSE PART 1 EXPECTED IN Q3 2024 & FROM MULTIPLE ASCENDING DOSE PART 2 IN Q1 2025   * NEUROBO PHARMACEUTICALS INC: PLANNED PART 3 INTERIM DATA READOUT EXPECTED MID-2026 WITH TOP-LINE DATA IN SECOND HALF OF 2026Source text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRBO"],"gpt_icon":0},{"id":"2446939336","title":"NeuroBo Pharmaceuticals Doses First Patient in the Mad Part 2 of Its Phase 1 Clinical Trial Evaluating Da-1726 for the Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2446939336","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446939336?lang=en_us&edition=fundamental","pubTime":"2024-06-26 21:06","pubTimestamp":1719407172,"startTime":"0","endTime":"0","summary":"NeuroBo Pharmaceuticals Doses First Patient in the Mad Part 2 of Its Phase 1 Clinical Trial Evaluating Da-1726 for the Treatment of Obesity","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240626:nTUA2CRXYH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRBO","BK4139"],"gpt_icon":0},{"id":"2446739313","title":"NeuroBo Pharmaceuticals: Top-Line Data Readout From Single Ascending Dose Part 1 Expected in Q3 2024 & From Multiple Ascending Dose Part 2 in Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2446739313","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446739313?lang=en_us&edition=fundamental","pubTime":"2024-06-26 21:06","pubTimestamp":1719407172,"startTime":"0","endTime":"0","summary":"NeuroBo Pharmaceuticals: Top-Line Data Readout From Single Ascending Dose Part 1 Expected in Q3 2024 & From Multiple Ascending Dose Part 2 in Q1 2025","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240626:nTUA2CRXYH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NRBO"],"gpt_icon":0},{"id":"2446393272","title":"NeuroBo Pharmaceuticals Inc: Planned Part 3 Interim Data Readout Expected Mid-2026 With Top-Line Data in Second Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2446393272","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446393272?lang=en_us&edition=fundamental","pubTime":"2024-06-26 21:06","pubTimestamp":1719407172,"startTime":"0","endTime":"0","summary":"NeuroBo Pharmaceuticals Inc: Planned Part 3 Interim Data Readout Expected Mid-2026 With Top-Line Data in Second Half of 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240626:nTUA2CRXYH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NRBO"],"gpt_icon":0},{"id":"2446395191","title":"NeuroBo Pharmaceuticals Doses First Patient in the MAD Part 2 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2446395191","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446395191?lang=en_us&edition=fundamental","pubTime":"2024-06-26 21:06","pubTimestamp":1719407160,"startTime":"0","endTime":"0","summary":"Top-Line Data Readout From the Single Ascending Dose Part 1 Expected in the Third Quarter of 2024, and From the Multiple Ascending Dose Part 2 in the First Quarter of 2025. Planned Part 3 Will Assess Total Weight Loss at 24 Weeks, Exploring Maximum Titratable Dose and Dietary Changes; Interim Data Readout Expected Mid-2026 with Top-Line Data in the Second Half of 2026. Recent Financing of up to $70 million Will Fund the Ongoing Clinical Development of DA-1726. \"We are now well capitalized to execute on our upcoming DA-1726 milestones following our recent, successful financing of up to $70 million in aggregate gross proceeds, with $20 million upfront and $50 million of clinical milestone-based warrants, which we expect will enable us to fully fund a planned multicenter, randomized, double-blind, placebo-controlled Part 3 of this Phase 1 trial, which would begin upon completion of Part 2. Part 3 will explore changes in baseline, at 24 weeks, for total weight loss, dietary changes, weight","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/WwUI1..i_t13HfHmASvq6Q--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/56eea11ca7d1fbdebfe95a94ba4c187e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/WwUI1..i_t13HfHmASvq6Q--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/56eea11ca7d1fbdebfe95a94ba4c187e"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/neurobo-pharmaceuticals-doses-first-patient-130600965.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurobo-pharmaceuticals-doses-first-patient-130600965.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OXM","BK4181","BK4218","PD","NRBO","LU1169589451.USD","BMI","BK4139","LU1169590202.USD","BK4023","BK4157","PK","BK4202"],"gpt_icon":0},{"id":"2446877680","title":"NeuroBo Pharmaceuticals Raises $20 Million from Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2446877680","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446877680?lang=en_us&edition=fundamental","pubTime":"2024-06-26 06:01","pubTimestamp":1719352876,"startTime":"0","endTime":"0","summary":"NeuroBo Pharmaceuticals  said late Tuesday it has raised about $20 million from its share offering through H.C. Wainwright as its placement agent.NeuroBo said it plans to use the proceeds for working capital and  and general corporate purposes.The potential additional proceeds to NeuroBo from its clinical milestone-linked Series Warrants, if fully exercised, will be about $50 million and will be used to fund the trial of DA-1726, the clinical-stage biotechnology company.The shares were up more than 8% in after-hours activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","NRBO"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":77,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NRBO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-29","symbol":"NRBO","oldSymbol":"NRBO","defaultRemindTime":1732890600000,"newSymbol":"MTVA","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1732856400000},{"market":"US","date":"2024-11-07","symbol":"NRBO","fiscalQuarterEnding":"2024/09","expectedEps":-0.82,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.55},{"market":"US","date":"2024-08-14","symbol":"NRBO","fiscalQuarterEnding":"2024/06","expectedEps":-1.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"pre","actualEps":-1.85},{"market":"US","date":"2024-05-09","symbol":"NRBO","fiscalQuarterEnding":"2024/03","expectedEps":-0.95,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-1.32},{"date":"2024-03-28","symbol":"NRBO","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711612800000,"name":null,"time":"Pre-Market","dateTimestamp":1711598400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NRBO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NRBO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NRBO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NRBO","date":"2024-11-27","current":-0.730091,"percent":0.930718,"low":-44.328872,"twenty":-4.180567,"median":-1.549047,"eighty":-0.929147,"high":-0.135024,"avg":-3.429469,"sd":4.762423,"marketCap":20247623},"quantilePoints":[{"date":"2020-05-15","current":-10.413512,"twenty":-21.446309,"median":-12.870149,"eighty":-10.951531,"marketCap":221932774},{"date":"2020-05-22","current":-16.924944,"twenty":-21.268861,"median":-12.899701,"eighty":-10.951531,"marketCap":225711052},{"date":"2020-05-29","current":-16.284407,"twenty":-21.045805,"median":-13.069629,"eighty":-10.990071,"marketCap":217168858},{"date":"2020-06-05","current":-16.912626,"twenty":-20.781375,"median":-13.270383,"eighty":-11.055226,"marketCap":225546779},{"date":"2020-06-12","current":-11.985422,"twenty":-20.284273,"median":-13.262358,"eighty":-11.092602,"marketCap":159837593},{"date":"2020-06-19","current":-11.541974,"twenty":-19.824444,"median":-13.143315,"eighty":-11.151201,"marketCap":153923767},{"date":"2020-06-26","current":-11.184752,"twenty":-19.218044,"median":-12.899701,"eighty":-11.185292,"marketCap":149159851},{"date":"2020-07-02","current":-10.568851,"twenty":-18.757024,"median":-12.652199,"eighty":-11.041729,"marketCap":140946203},{"date":"2020-07-10","current":-9.780499,"twenty":-18.514692,"median":-12.397308,"eighty":-10.791204,"marketCap":130432733},{"date":"2020-07-17","current":-10.679713,"twenty":-18.128119,"median":-12.311435,"eighty":-10.607754,"marketCap":142424659},{"date":"2020-07-24","current":-8.868966,"twenty":-17.590116,"median":-12.194829,"eighty":-10.425845,"marketCap":118276534},{"date":"2020-07-31","current":-7.895844,"twenty":-17.479254,"median":-12.126128,"eighty":-10.222472,"marketCap":105298969},{"date":"2020-08-07","current":-8.16684,"twenty":-17.368392,"median":-12.101782,"eighty":-10.052026,"marketCap":108912974},{"date":"2020-08-14","current":-4.485572,"twenty":-17.306787,"median":-12.016217,"eighty":-9.917678,"marketCap":107927337},{"date":"2020-08-21","current":-4.260269,"twenty":-17.162659,"median":-11.954019,"eighty":-9.812526,"marketCap":102506329},{"date":"2020-08-28","current":-4.314888,"twenty":-17.021024,"median":-11.714426,"eighty":-9.536603,"marketCap":103820513},{"date":"2020-09-04","current":-4.171513,"twenty":-16.920017,"median":-11.681479,"eighty":-9.376469,"marketCap":100370781},{"date":"2020-09-11","current":-3.959865,"twenty":-16.873208,"median":-11.62262,"eighty":-8.883748,"marketCap":95278319},{"date":"2020-09-18","current":-4.369507,"twenty":-16.685275,"median":-11.525011,"eighty":-8.35348,"marketCap":105134697},{"date":"2020-09-25","current":-3.925729,"twenty":-16.508259,"median":-11.477217,"eighty":-8.124959,"marketCap":94456954},{"date":"2020-10-02","current":-3.789181,"twenty":-16.272089,"median":-11.285522,"eighty":-7.659338,"marketCap":91171494},{"date":"2020-10-09","current":-4.383161,"twenty":-16.220172,"median":-11.185652,"eighty":-4.433683,"marketCap":105463242},{"date":"2020-10-16","current":-4.485572,"twenty":-16.190382,"median":-11.090871,"eighty":-4.396816,"marketCap":107927337},{"date":"2020-10-23","current":-4.260269,"twenty":-16.095982,"median":-10.953073,"eighty":-4.349024,"marketCap":102506329},{"date":"2020-10-30","current":-3.427332,"twenty":-16.006351,"median":-10.791204,"eighty":-4.317619,"marketCap":82465027},{"date":"2020-11-06","current":-3.50926,"twenty":-15.92851,"median":-10.679713,"eighty":-4.288944,"marketCap":84436303},{"date":"2020-11-13","current":-3.677857,"twenty":-15.831305,"median":-10.575969,"eighty":-4.263,"marketCap":86407578},{"date":"2020-11-20","current":-3.747778,"twenty":-15.388459,"median":-10.444344,"eighty":-4.189264,"marketCap":88050308},{"date":"2020-11-27","current":-3.789731,"twenty":-15.151151,"median":-10.259352,"eighty":-4.171513,"marketCap":89035946},{"date":"2020-12-04","current":-3.810708,"twenty":-15.083402,"median":-10.222888,"eighty":-4.123722,"marketCap":89528765},{"date":"2020-12-11","current":-3.803716,"twenty":-14.406883,"median":-10.143732,"eighty":-3.987175,"marketCap":89364492},{"date":"2020-12-18","current":-4.265196,"twenty":-13.978371,"median":-10.015923,"eighty":-3.987175,"marketCap":100206508},{"date":"2020-12-24","current":-4.258204,"twenty":-13.74195,"median":-9.936576,"eighty":-3.997031,"marketCap":100042234},{"date":"2020-12-31","current":-3.670865,"twenty":-13.658642,"median":-9.89752,"eighty":-3.987175,"marketCap":86243305},{"date":"2021-01-08","current":-5.23303,"twenty":-13.524857,"median":-9.842089,"eighty":-3.987175,"marketCap":122944810},{"date":"2021-01-15","current":-5.048827,"twenty":-13.446425,"median":-9.688481,"eighty":-3.987175,"marketCap":118617152},{"date":"2021-01-22","current":-4.841154,"twenty":-13.446425,"median":-9.540298,"eighty":-3.987175,"marketCap":113738061},{"date":"2021-01-29","current":-4.831717,"twenty":-13.38732,"median":-9.472549,"eighty":-3.992103,"marketCap":113516349},{"date":"2021-02-05","current":-4.94496,"twenty":-13.28735,"median":-9.244665,"eighty":-4.010682,"marketCap":116176889},{"date":"2021-02-12","current":-5.199758,"twenty":-13.263963,"median":-8.868966,"eighty":-4.033057,"marketCap":122163103},{"date":"2021-02-19","current":-5.086514,"twenty":-13.236601,"median":-8.647242,"eighty":-4.044248,"marketCap":119502563},{"date":"2021-02-26","current":-4.029576,"twenty":-13.161203,"median":-8.253066,"eighty":-4.044248,"marketCap":94670862},{"date":"2021-03-05","current":-3.70872,"twenty":-13.109369,"median":-8.154522,"eighty":-4.03195,"marketCap":87132666},{"date":"2021-03-12","current":-4.180567,"twenty":-12.964717,"median":-8.086773,"eighty":-4.03195,"marketCap":98218247},{"date":"2021-03-19","current":-4.491987,"twenty":-12.917433,"median":-7.600211,"eighty":-4.044248,"marketCap":105534731},{"date":"2021-03-26","current":-4.246626,"twenty":-12.840596,"median":-5.523809,"eighty":-4.058179,"marketCap":99770229},{"date":"2021-04-01","current":-4.369306,"twenty":-12.722386,"median":-5.374341,"eighty":-4.055448,"marketCap":102652480},{"date":"2021-04-09","current":-3.699283,"twenty":-12.582012,"median":-5.341312,"eighty":-4.027463,"marketCap":86910955},{"date":"2021-04-16","current":-2.412995,"twenty":-12.545071,"median":-5.225831,"eighty":-3.987175,"marketCap":71612853},{"date":"2021-04-23","current":-2.666994,"twenty":-12.397308,"median":-5.17442,"eighty":-3.980347,"marketCap":79151048},{"date":"2021-04-30","current":-2.681935,"twenty":-12.352979,"median":-5.102759,"eighty":-3.925729,"marketCap":79594471},{"date":"2021-05-07","current":-2.203819,"twenty":-12.338203,"median":-5.086514,"eighty":-3.891592,"marketCap":65404928},{"date":"2021-05-14","current":-2.151525,"twenty":-12.284668,"median":-5.048796,"eighty":-3.850274,"marketCap":63852946},{"date":"2021-05-21","current":-2.219312,"twenty":-12.231783,"median":-4.956726,"eighty":-3.824692,"marketCap":62744388},{"date":"2021-05-28","current":-2.21147,"twenty":-12.194829,"median":-4.929911,"eighty":-3.810708,"marketCap":62522676},{"date":"2021-06-04","current":-2.407522,"twenty":-12.145557,"median":-4.88362,"eighty":-3.803038,"marketCap":68065467},{"date":"2021-06-11","current":-2.438891,"twenty":-12.131716,"median":-4.831717,"eighty":-3.789621,"marketCap":68952314},{"date":"2021-06-18","current":-2.577584,"twenty":-12.123004,"median":-4.60523,"eighty":-3.775747,"marketCap":72873461},{"date":"2021-06-25","current":-2.561819,"twenty":-12.10561,"median":-4.499226,"eighty":-3.747516,"marketCap":72427752},{"date":"2021-07-02","current":-2.364756,"twenty":-12.101782,"median":-4.485572,"eighty":-3.706833,"marketCap":66856386},{"date":"2021-07-09","current":-2.412051,"twenty":-12.091092,"median":-4.479342,"eighty":-3.67506,"marketCap":68193513},{"date":"2021-07-16","current":-2.151928,"twenty":-12.061794,"median":-4.460975,"eighty":-3.623959,"marketCap":60839311},{"date":"2021-07-23","current":-2.419934,"twenty":-12.010058,"median":-4.429745,"eighty":-3.585726,"marketCap":68416369},{"date":"2021-07-30","current":-2.593349,"twenty":-11.984312,"median":-4.416491,"eighty":-3.548292,"marketCap":73319170},{"date":"2021-08-06","current":-2.916533,"twenty":-11.96584,"median":-4.380952,"eighty":-3.4642,"marketCap":82456210},{"date":"2021-08-13","current":-2.790412,"twenty":-11.832436,"median":-4.369306,"eighty":-3.015852,"marketCap":78890536},{"date":"2021-08-20","current":-2.474584,"twenty":-11.736598,"median":-4.347266,"eighty":-2.87712,"marketCap":73764879},{"date":"2021-08-27","current":-2.953054,"twenty":-11.711962,"median":-4.33537,"eighty":-2.827018,"marketCap":88027575},{"date":"2021-09-03","current":-3.125004,"twenty":-11.692518,"median":-4.31801,"eighty":-2.848448,"marketCap":93153232},{"date":"2021-09-10","current":-3.117527,"twenty":-11.684267,"median":-4.303978,"eighty":-2.853472,"marketCap":92930377},{"date":"2021-09-17","current":-3.177336,"twenty":-11.664521,"median":-4.294406,"eighty":-2.866391,"marketCap":94713214},{"date":"2021-09-24","current":-2.855865,"twenty":-11.632499,"median":-4.290694,"eighty":-2.867827,"marketCap":85130465},{"date":"2021-10-01","current":-1.869021,"twenty":-11.601457,"median":-4.284374,"eighty":-2.831941,"marketCap":55713655},{"date":"2021-10-08","current":-1.73071,"twenty":-11.558617,"median":-4.273924,"eighty":-2.784827,"marketCap":51590743},{"date":"2021-10-15","current":-1.695026,"twenty":-11.528404,"median":-4.265196,"eighty":-2.74889,"marketCap":50527016},{"date":"2021-10-22","current":-1.65042,"twenty":-11.503211,"median":-4.259237,"eighty":-2.699171,"marketCap":49197357},{"date":"2021-10-29","current":-1.57905,"twenty":-11.488459,"median":-4.246626,"eighty":-2.678637,"marketCap":47069904},{"date":"2021-11-05","current":-1.784148,"twenty":-11.449468,"median":-4.213596,"eighty":-2.659523,"marketCap":53183672},{"date":"2021-11-12","current":-1.614735,"twenty":-11.383983,"median":-4.185168,"eighty":-2.638271,"marketCap":48133631},{"date":"2021-11-19","current":-1.399362,"twenty":-11.298056,"median":-4.182868,"eighty":-2.592712,"marketCap":42283134},{"date":"2021-11-26","current":-1.566582,"twenty":-11.219846,"median":-4.17604,"eighty":-2.563396,"marketCap":47335836},{"date":"2021-12-03","current":-1.214541,"twenty":-11.203383,"median":-4.152256,"eighty":-2.523983,"marketCap":36698569},{"date":"2021-12-10","current":-1.223342,"twenty":-11.185472,"median":-4.14868,"eighty":-2.484509,"marketCap":36964500},{"date":"2021-12-17","current":-1.249745,"twenty":-11.167707,"median":-4.123722,"eighty":-2.442982,"marketCap":37762296},{"date":"2021-12-23","current":-1.333355,"twenty":-11.099525,"median":-4.105072,"eighty":-2.419934,"marketCap":40288646},{"date":"2021-12-31","current":-1.073725,"twenty":-11.082218,"median":-4.062276,"eighty":-2.407522,"marketCap":32443662},{"date":"2022-01-07","current":-1.311352,"twenty":-11.014737,"median":-4.029576,"eighty":-2.388404,"marketCap":39623817},{"date":"2022-01-14","current":-1.152934,"twenty":-10.953073,"median":-4.009817,"eighty":-2.364756,"marketCap":34837047},{"date":"2022-01-21","current":-0.985714,"twenty":-10.946907,"median":-3.989502,"eighty":-2.339532,"marketCap":29784346},{"date":"2022-01-28","current":-0.888903,"twenty":-10.822036,"median":-3.987175,"eighty":-2.312649,"marketCap":26859097},{"date":"2022-02-04","current":-0.851323,"twenty":-10.791204,"median":-3.97352,"eighty":-2.264796,"marketCap":25723570},{"date":"2022-02-11","current":-0.787867,"twenty":-10.716668,"median":-3.946211,"eighty":-2.222159,"marketCap":23806201},{"date":"2022-02-18","current":-0.744742,"twenty":-10.683377,"median":-3.896516,"eighty":-2.209795,"marketCap":22503137},{"date":"2022-02-25","current":-0.682519,"twenty":-10.658736,"median":-3.891592,"eighty":-2.192986,"marketCap":20623000},{"date":"2022-03-04","current":-0.677679,"twenty":-10.607754,"median":-3.873637,"eighty":-2.151767,"marketCap":20476738},{"date":"2022-03-11","current":-0.665181,"twenty":-10.574546,"median":-3.847037,"eighty":-2.026673,"marketCap":20099114},{"date":"2022-03-18","current":-0.739286,"twenty":-10.525868,"median":-3.831684,"eighty":-1.810109,"marketCap":22338259},{"date":"2022-03-25","current":-0.8581,"twenty":-10.465491,"median":-3.824005,"eighty":-1.748553,"marketCap":25928337},{"date":"2022-04-01","current":-1.569805,"twenty":-10.425845,"median":-3.810708,"eighty":-1.718221,"marketCap":23992904},{"date":"2022-04-08","current":-1.526369,"twenty":-10.321016,"median":-3.803402,"eighty":-1.691457,"marketCap":23329028},{"date":"2022-04-14","current":-1.516426,"twenty":-10.250117,"median":-3.796284,"eighty":-1.67183,"marketCap":23177056},{"date":"2022-04-22","current":-1.382716,"twenty":-10.231744,"median":-3.789731,"eighty":-1.645067,"marketCap":21133432},{"date":"2022-04-29","current":-1.121663,"twenty":-10.223303,"median":-3.782739,"eighty":-1.605814,"marketCap":17143502},{"date":"2022-05-06","current":-1.064097,"twenty":-10.217139,"median":-3.775747,"eighty":-1.575806,"marketCap":16263665},{"date":"2022-05-13","current":-0.915144,"twenty":-10.18447,"median":-3.754771,"eighty":-1.569701,"marketCap":13576161},{"date":"2022-05-20","current":-0.910651,"twenty":-10.12215,"median":-3.740786,"eighty":-1.550024,"marketCap":13509506},{"date":"2022-05-27","current":-0.774961,"twenty":-10.064609,"median":-3.704001,"eighty":-1.524171,"marketCap":11496544},{"date":"2022-06-03","current":-0.799403,"twenty":-10.022485,"median":-3.685728,"eighty":-1.51517,"marketCap":11859144},{"date":"2022-06-10","current":-0.834629,"twenty":-9.994581,"median":-3.649889,"eighty":-1.425765,"marketCap":12381714},{"date":"2022-06-17","current":-0.759505,"twenty":-9.946401,"median":-3.621911,"eighty":-1.386045,"marketCap":11267253},{"date":"2022-06-24","current":-0.816836,"twenty":-9.9202,"median":-3.602976,"eighty":-1.355357,"marketCap":12117763},{"date":"2022-07-01","current":-0.844693,"twenty":-9.915997,"median":-3.577533,"eighty":-1.336227,"marketCap":12531020},{"date":"2022-07-08","current":-0.993862,"twenty":-9.886434,"median":-3.567166,"eighty":-1.318393,"marketCap":14743945},{"date":"2022-07-15","current":-1.006622,"twenty":-9.868804,"median":-3.539017,"eighty":-1.274388,"marketCap":14933243},{"date":"2022-07-22","current":-0.886029,"twenty":-9.84692,"median":-3.488778,"eighty":-1.248132,"marketCap":13144240},{"date":"2022-07-29","current":-0.757348,"twenty":-9.802671,"median":-3.289477,"eighty":-1.230383,"marketCap":11235259},{"date":"2022-08-05","current":-0.670363,"twenty":-9.782963,"median":-3.147432,"eighty":-1.214541,"marketCap":9944831},{"date":"2022-08-12","current":-0.748449,"twenty":-9.633271,"median":-3.121265,"eighty":-1.156454,"marketCap":10640702},{"date":"2022-08-19","current":-0.714881,"twenty":-9.566313,"median":-3.095099,"eighty":-1.116046,"marketCap":10163457},{"date":"2022-08-26","current":-0.749762,"twenty":-9.529212,"median":-3.039029,"eighty":-1.080766,"marketCap":10659365},{"date":"2022-09-02","current":-0.57348,"twenty":-9.513502,"median":-2.99791,"eighty":-1.068283,"marketCap":8153161},{"date":"2022-09-09","current":-0.517782,"twenty":-9.488098,"median":-2.975482,"eighty":-1.053095,"marketCap":7361308},{"date":"2022-09-16","current":-1.120204,"twenty":-9.450377,"median":-2.938101,"eighty":-1.052339,"marketCap":15925934},{"date":"2022-09-23","current":-0.971426,"twenty":-9.376469,"median":-2.916533,"eighty":-1.039248,"marketCap":13810770},{"date":"2022-09-30","current":-0.85578,"twenty":-9.226188,"median":-2.904686,"eighty":-1.015533,"marketCap":12166631},{"date":"2022-10-07","current":-0.724507,"twenty":-9.026636,"median":-2.885769,"eighty":-1.006334,"marketCap":10300311},{"date":"2022-10-14","current":-0.79702,"twenty":-8.898529,"median":-2.853472,"eighty":-0.987368,"marketCap":11331231},{"date":"2022-10-21","current":-0.63449,"twenty":-8.735932,"median":-2.82596,"eighty":-0.976302,"marketCap":9020548},{"date":"2022-10-28","current":-0.522595,"twenty":-8.647242,"median":-2.796972,"eighty":-0.950584,"marketCap":7429732},{"date":"2022-11-04","current":-0.163155,"twenty":-8.534598,"median":-2.774647,"eighty":-0.9206,"marketCap":2319569},{"date":"2022-11-11","current":-0.388894,"twenty":-8.379985,"median":-2.750182,"eighty":-0.912859,"marketCap":5528903},{"date":"2022-11-18","current":-0.614292,"twenty":-8.238284,"median":-2.726759,"eighty":-0.903419,"marketCap":8519621},{"date":"2022-11-25","current":-0.717456,"twenty":-8.174231,"median":-2.689406,"eighty":-0.897994,"marketCap":9950397},{"date":"2022-12-02","current":-0.736213,"twenty":-8.161913,"median":-2.681935,"eighty":-0.880637,"marketCap":10210538},{"date":"2022-12-09","current":-0.829998,"twenty":-8.13974,"median":-2.666994,"eighty":-0.863898,"marketCap":11511244},{"date":"2022-12-16","current":-0.679942,"twenty":-8.107714,"median":-2.659523,"eighty":-0.851834,"marketCap":9430115},{"date":"2022-12-23","current":-1.112413,"twenty":-8.088005,"median":-2.65401,"eighty":-0.849185,"marketCap":15428051},{"date":"2022-12-30","current":-0.9815,"twenty":-8.04366,"median":-2.632762,"eighty":-0.849613,"marketCap":13612428},{"date":"2023-01-06","current":-0.967,"twenty":-7.895844,"median":-2.624879,"eighty":-0.851323,"marketCap":13411325},{"date":"2023-01-13","current":-1.053044,"twenty":-7.600211,"median":-2.584936,"eighty":-0.852601,"marketCap":14604665},{"date":"2023-01-20","current":-1.114875,"twenty":-6.389506,"median":-2.56576,"eighty":-0.855144,"marketCap":15462201},{"date":"2023-01-27","current":-1.107625,"twenty":-5.691816,"median":-2.546054,"eighty":-0.857636,"marketCap":15361649},{"date":"2023-02-03","current":-1.110771,"twenty":-5.482257,"median":-2.515938,"eighty":-0.861465,"marketCap":15405285},{"date":"2023-02-10","current":-0.992444,"twenty":-5.409257,"median":-2.501627,"eighty":-0.865489,"marketCap":13764204},{"date":"2023-02-17","current":-0.971241,"twenty":-5.360186,"median":-2.468501,"eighty":-0.869571,"marketCap":13470138},{"date":"2023-02-24","current":-0.783148,"twenty":-5.345087,"median":-2.449118,"eighty":-0.864693,"marketCap":10861484},{"date":"2023-03-03","current":-1.04511,"twenty":-5.341312,"median":-2.431048,"eighty":-0.86875,"marketCap":14494627},{"date":"2023-03-10","current":-0.989434,"twenty":-5.296014,"median":-2.413885,"eighty":-0.873366,"marketCap":13722466},{"date":"2023-03-17","current":-0.943882,"twenty":-5.246144,"median":-2.407522,"eighty":-0.87543,"marketCap":13090697},{"date":"2023-03-24","current":-0.889164,"twenty":-5.224391,"median":-2.390121,"eighty":-0.875485,"marketCap":12331816},{"date":"2023-03-31","current":-0.964834,"twenty":-5.207307,"median":-2.383996,"eighty":-0.875557,"marketCap":13475830},{"date":"2023-04-06","current":-1.40096,"twenty":-5.189623,"median":-2.364756,"eighty":-0.877618,"marketCap":19567213},{"date":"2023-04-14","current":-1.413997,"twenty":-5.150582,"median":-2.341109,"eighty":-0.880637,"marketCap":19749296},{"date":"2023-04-21","current":-1.342587,"twenty":-5.114825,"median":-2.333226,"eighty":-0.882794,"marketCap":18751912},{"date":"2023-04-28","current":-1.314373,"twenty":-5.105172,"median":-2.315439,"eighty":-0.887179,"marketCap":18357850},{"date":"2023-05-05","current":-1.167467,"twenty":-5.089021,"median":-2.289891,"eighty":-0.889007,"marketCap":16306011},{"date":"2023-05-12","current":-1.126606,"twenty":-5.086514,"median":-2.262443,"eighty":-0.89258,"marketCap":15735300},{"date":"2023-05-19","current":-1.197909,"twenty":-5.082739,"median":-2.234996,"eighty":-0.897994,"marketCap":16406564},{"date":"2023-05-26","current":-1.131357,"twenty":-5.065777,"median":-2.219312,"eighty":-0.898502,"marketCap":15495070},{"date":"2023-06-02","current":-1.093765,"twenty":-5.048815,"median":-2.211379,"eighty":-0.898646,"marketCap":14980202},{"date":"2023-06-09","current":-0.990534,"twenty":-5.038731,"median":-2.203819,"eighty":-0.8996,"marketCap":13566359},{"date":"2023-06-16","current":-0.982379,"twenty":-4.990217,"median":-2.177205,"eighty":-0.903576,"marketCap":13454668},{"date":"2023-06-23","current":-0.778305,"twenty":-4.956726,"median":-2.155869,"eighty":-0.89861,"marketCap":10659671},{"date":"2023-06-30","current":-0.870596,"twenty":-4.954863,"median":-2.150129,"eighty":-0.889112,"marketCap":11923685},{"date":"2023-07-07","current":-0.872784,"twenty":-4.948735,"median":-2.091835,"eighty":-0.883872,"marketCap":11953651},{"date":"2023-07-14","current":-0.891083,"twenty":-4.926901,"median":-1.873449,"eighty":-0.879326,"marketCap":12204274},{"date":"2023-07-21","current":-0.970246,"twenty":-4.910272,"median":-1.842242,"eighty":-0.876657,"marketCap":13288493},{"date":"2023-07-28","current":-0.998292,"twenty":-4.878901,"median":-1.793159,"eighty":-0.879326,"marketCap":13672601},{"date":"2023-08-04","current":-1.026337,"twenty":-4.848703,"median":-1.756601,"eighty":-0.880637,"marketCap":14056709},{"date":"2023-08-11","current":-1.467726,"twenty":-4.835492,"median":-1.73071,"eighty":-0.883872,"marketCap":16331390},{"date":"2023-08-18","current":-1.999685,"twenty":-4.775095,"median":-1.756601,"eighty":-0.887753,"marketCap":22250498},{"date":"2023-08-25","current":-1.814913,"twenty":-4.669401,"median":-1.793159,"eighty":-0.88906,"marketCap":20194536},{"date":"2023-09-01","current":-1.537236,"twenty":-4.601455,"median":-1.763361,"eighty":-0.890315,"marketCap":17104830},{"date":"2023-09-08","current":-1.581789,"twenty":-4.551504,"median":-1.748553,"eighty":-0.892595,"marketCap":17600566},{"date":"2023-09-15","current":-1.56901,"twenty":-4.499226,"median":-1.740659,"eighty":-0.894862,"marketCap":17458378},{"date":"2023-09-20","current":-1.827001,"twenty":-4.499226,"median":-1.744606,"eighty":-0.89543,"marketCap":20329038},{"date":"2023-09-29","current":-1.642919,"twenty":-4.499226,"median":-1.735685,"eighty":-0.896567,"marketCap":18280763},{"date":"2023-10-05","current":-1.55416,"twenty":-4.497778,"median":-1.73071,"eighty":-0.897849,"marketCap":17293133},{"date":"2023-10-13","current":-1.61978,"twenty":-4.493435,"median":-1.724317,"eighty":-0.898285,"marketCap":18023287},{"date":"2023-10-20","current":-1.5027,"twenty":-4.488138,"median":-1.712868,"eighty":-0.898538,"marketCap":16720538},{"date":"2023-10-27","current":-1.516169,"twenty":-4.485572,"median":-1.708408,"eighty":-0.89861,"marketCap":16870412},{"date":"2023-11-03","current":-1.429136,"twenty":-4.485572,"median":-1.692307,"eighty":-0.898789,"marketCap":15901996},{"date":"2023-11-10","current":-1.505808,"twenty":-4.485572,"median":-1.686104,"eighty":-0.899039,"marketCap":16755124},{"date":"2023-11-17","current":-1.390102,"twenty":-4.473113,"median":-1.668262,"eighty":-0.902844,"marketCap":16447691},{"date":"2023-11-24","current":-1.410529,"twenty":-4.472156,"median":-1.659341,"eighty":-0.905773,"marketCap":16689382},{"date":"2023-12-01","current":-1.469575,"twenty":-4.463163,"median":-1.644992,"eighty":-0.909822,"marketCap":17388008},{"date":"2023-12-08","current":-1.669673,"twenty":-4.448037,"median":-1.642919,"eighty":-0.911082,"marketCap":19755571},{"date":"2023-12-15","current":-1.637854,"twenty":-4.437252,"median":-1.642208,"eighty":-0.912371,"marketCap":19379090},{"date":"2023-12-22","current":-1.433081,"twenty":-4.426373,"median":-1.640806,"eighty":-0.912923,"marketCap":16956216},{"date":"2023-12-29","current":-1.640396,"twenty":-4.421071,"median":-1.639945,"eighty":-0.913773,"marketCap":19409166},{"date":"2024-01-05","current":-1.656552,"twenty":-4.416491,"median":-1.640806,"eighty":-0.914951,"marketCap":19600318},{"date":"2024-01-12","current":-1.320321,"twenty":-4.416491,"median":-1.638674,"eighty":-0.915144,"marketCap":15622036},{"date":"2024-01-19","current":-1.406429,"twenty":-4.395289,"median":-1.623233,"eighty":-0.915274,"marketCap":16640864},{"date":"2024-01-26","current":-1.279276,"twenty":-4.384527,"median":-1.614996,"eighty":-0.915306,"marketCap":15136394},{"date":"2024-02-02","current":-2.242905,"twenty":-4.379627,"median":-1.614321,"eighty":-0.91628,"marketCap":26538055},{"date":"2024-02-09","current":-1.775462,"twenty":-4.371354,"median":-1.61978,"eighty":-0.916523,"marketCap":21007272},{"date":"2024-02-16","current":-1.980481,"twenty":-4.369346,"median":-1.630543,"eighty":-0.916961,"marketCap":23433054},{"date":"2024-02-23","current":-2.351155,"twenty":-4.357137,"median":-1.639945,"eighty":-0.920764,"marketCap":27818867},{"date":"2024-03-01","current":-2.374117,"twenty":-4.349024,"median":-1.641498,"eighty":-0.92339,"marketCap":28090555},{"date":"2024-03-08","current":-2.238805,"twenty":-4.346914,"median":-1.646559,"eighty":-0.923878,"marketCap":26489539},{"date":"2024-03-15","current":-1.865671,"twenty":-4.339425,"median":-1.65524,"eighty":-0.927855,"marketCap":22074616},{"date":"2024-03-22","current":-1.877972,"twenty":-4.33537,"median":-1.659341,"eighty":-0.934853,"marketCap":22220163},{"date":"2024-03-28","current":-1.779563,"twenty":-4.332639,"median":-1.668967,"eighty":-0.938409,"marketCap":21055787},{"date":"2024-04-05","current":-1.53043,"twenty":-4.325578,"median":-1.659341,"eighty":-0.94022,"marketCap":19084464},{"date":"2024-04-12","current":-1.408468,"twenty":-4.318635,"median":-1.65283,"eighty":-0.942578,"marketCap":17563594},{"date":"2024-04-19","current":-1.353388,"twenty":-4.314007,"median":-1.646055,"eighty":-0.943882,"marketCap":16876750},{"date":"2024-04-26","current":-1.203886,"twenty":-4.305719,"median":-1.641152,"eighty":-0.945398,"marketCap":15012457},{"date":"2024-05-03","current":-1.467473,"twenty":-4.294925,"median":-1.639494,"eighty":-0.948399,"marketCap":18299387},{"date":"2024-05-10","current":-1.57173,"twenty":-4.294406,"median":-1.623233,"eighty":-0.949983,"marketCap":19599477},{"date":"2024-05-17","current":-1.361134,"twenty":-4.294406,"median":-1.614996,"eighty":-0.951444,"marketCap":22567609},{"date":"2024-05-24","current":-1.176198,"twenty":-4.294168,"median":-1.612248,"eighty":-0.953408,"marketCap":19501357},{"date":"2024-05-31","current":-1.201349,"twenty":-4.292564,"median":-1.608231,"eighty":-0.955298,"marketCap":19918368},{"date":"2024-06-07","current":-1.192472,"twenty":-4.287297,"median":-1.605814,"eighty":-0.95801,"marketCap":19771188},{"date":"2024-06-14","current":-1.159923,"twenty":-4.286172,"median":-1.602511,"eighty":-0.959808,"marketCap":19231527},{"date":"2024-06-21","current":-1.213185,"twenty":-4.284734,"median":-1.597313,"eighty":-0.960362,"marketCap":20114608},{"date":"2024-06-28","current":-2.893625,"twenty":-4.282487,"median":-1.597313,"eighty":-0.9605,"marketCap":47976297},{"date":"2024-07-05","current":-2.694809,"twenty":-4.274937,"median":-1.602511,"eighty":-0.9605,"marketCap":44679926},{"date":"2024-07-12","current":-2.308609,"twenty":-4.273924,"median":-1.605889,"eighty":-0.964834,"marketCap":38276732},{"date":"2024-07-15","current":-2.477048,"twenty":-4.273924,"median":-1.605965,"eighty":-0.964834,"marketCap":41069455},{"date":"2024-08-02","current":-1.874278,"twenty":-4.273924,"median":-1.606656,"eighty":-0.964834,"marketCap":31075523},{"date":"2024-08-09","current":-1.938778,"twenty":-4.273924,"median":-1.610587,"eighty":-0.9657,"marketCap":32144944},{"date":"2024-08-16","current":-1.27386,"twenty":-4.270433,"median":-1.614321,"eighty":-0.96727,"marketCap":32991710},{"date":"2024-08-23","current":-1.196062,"twenty":-4.263225,"median":-1.609115,"eighty":-0.967988,"marketCap":30976805},{"date":"2024-08-30","current":-1.150185,"twenty":-4.260269,"median":-1.605889,"eighty":-0.969172,"marketCap":29788653},{"date":"2024-09-06","current":-1.100147,"twenty":-4.259856,"median":-1.604163,"eighty":-0.970332,"marketCap":28492720},{"date":"2024-09-13","current":-1.196062,"twenty":-4.256805,"median":-1.597313,"eighty":-0.970791,"marketCap":30976805},{"date":"2024-09-20","current":-1.068263,"twenty":-4.250294,"median":-1.590533,"eighty":-0.971241,"marketCap":27666954},{"date":"2024-09-27","current":-1.078094,"twenty":-4.243893,"median":-1.581789,"eighty":-0.971241,"marketCap":27921558},{"date":"2024-10-04","current":-0.868374,"twenty":-4.23003,"median":-1.574094,"eighty":-0.970791,"marketCap":22490009},{"date":"2024-10-11","current":-0.80939,"twenty":-4.216428,"median":-1.571428,"eighty":-0.967135,"marketCap":20962386},{"date":"2024-10-18","current":-1.035495,"twenty":-4.208232,"median":-1.569805,"eighty":-0.964834,"marketCap":26818275},{"date":"2024-10-25","current":-0.917527,"twenty":-4.201554,"median":-1.56901,"eighty":-0.960201,"marketCap":23763028},{"date":"2024-10-31","current":-0.868374,"twenty":-4.185168,"median":-1.563139,"eighty":-0.956849,"marketCap":22490009},{"date":"2024-11-08","current":-0.820128,"twenty":-4.185168,"median":-1.557786,"eighty":-0.94949,"marketCap":22744613},{"date":"2024-11-15","current":-0.742518,"twenty":-4.185168,"median":-1.55416,"eighty":-0.943742,"marketCap":20592263},{"date":"2024-11-22","current":-0.730091,"twenty":-4.180567,"median":-1.551511,"eighty":-0.937188,"marketCap":20247623},{"date":"2024-11-27","current":-0.730091,"twenty":-4.180567,"median":-1.549047,"eighty":-0.929147,"marketCap":20247623}],"updateTime":1747011692883}}}